Skip to content

Pericardiotomy in Cardiac Surgery

Pericardiotomy in Cardiac Surgery Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06486636
Acronym
PRINCE
Enrollment
1400
Registered
2024-07-03
Start date
2024-10-21
Completion date
2031-09-01
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Atrial Flutter, Cardiac Events

Keywords

Pericardiotomy, Cardiac Surgery, Hospital Readmission, Post-Operative Atrial Fibrillation

Brief summary

PRINCE is an international, multicentre, randomized controlled trial of posterior pericardiotomy in patients without a history of atrial fibrillation (AF) or flutter undergoing cardiac surgery.

Detailed description

Approximately 30% of cardiac surgical patients develop post-operative atrial fibrillation (POAF). Its incidence varies depending on the type of cardiac operation. POAF is associated with short- and long-term adverse events, including mortality, stroke, and heart failure. POAF has also been significantly associated with unplanned hospitalization for heart failure. During cardiac surgery, pericardial fluid tends to collect posterior to the left atrium. Even small amounts of fluid may trigger atrial arrhythmias. A posterior left pericardiotomy is a surgical procedure that involves cauterizing an opening between the left inferior pulmonary vein and the diaphragm. This procedure may allow for more prolonged drainage of the pericardial fluid into the left pleural space. Recent research evidence found that posterior pericardiotomy was associated with a significantly lower incidence of POAF. The existing data on posterior pericardiotomy is promising for a reduction in POAF. However, no high-quality study has demonstrated that this reduction improves clinical outcomes in the years after cardiac surgery. The PRINCE trial's long-term follow-up of patients randomized to left posterior pericardiotomy could conclusively demonstrate whether the relationship of POAF to post-discharge clinical outcomes is causal and modifiable. The PRINCE trial will evaluate the effectiveness and safety of posterior left pericardiotomy in preventing POAF and improving post-discharge clinical outcomes in a broad spectrum of cardiac surgery patients. The intervention under investigation is left posterior pericardiotomy which is compared to no posterior pericardiotomy during cardiac surgery. The early co-primary outcome is in-hospital POAF, and the late co-primary outcome is the hierarchical composite of time to all-cause death, time to ischemic stroke, time to systemic arterial embolism, time to unplanned hospital visit/readmission for cardiac reasons, and time to atrial fibrillation after index hospital discharge. The study will enrol 1400 patients from 30 centres, globally. Follow-up visits will be performed in person or by telephone 1 and 6 months post-randomization (+7 days), and then every 6 months (+30 days) until an average follow-up of 5 years for the study participants (estimated to be 4 years after completion of enrolment).

Interventions

PROCEDURELeft Posterior Pericardiotomy

The surgeon will perform a left posterior pericardiotomy while the patient is on cardiopulmonary bypass. A soft channel drain will be put into place at an angle directed toward the posterior pericardium. The surgeon will grasp the pericardium and use cautery to make a 4- to 5-cm opening between the left inferior pulmonary vein and the diaphragm. The previously prepared channel drain is cut to the desired length and placed through the pericardiotomy along the diaphragm and into the pleural space.

Sponsors

McMaster University
CollaboratorOTHER
Hamilton Health Sciences Corporation
CollaboratorOTHER
Weill Medical College of Cornell University
CollaboratorOTHER
Population Health Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Blinding to allocation will be maintained for all parties, excluding the operating surgeon and necessary operating room personnel.

Intervention model description

Each patient will be assigned in a blinded fashion to one of two groups (left posterior pericardiotomy or no posterior pericardiotomy) in a 1:1 ratio.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients greater than or equal to 18 years of age * Requiring surgical intervention on the proximal aorta, cardiac valves, and/or coronary arteries * Able to provide informed consent

Exclusion criteria

* History of atrial fibrillation or flutter * Cardiac surgery procedures not included in the inclusion criteria (planned ventricular assistance device, aortic arch, transplantation surgery) * Prior cardiac surgery requiring opening of the pericardium * Previous surgical instrumentation of the left pleural cavity * Patient undergoing minimally invasive cardiac surgery

Design outcomes

Primary

MeasureTime frameDescription
In-hospital post-operative atrial fibrillationWithin 5 days after index cardiac surgeryNumber of patients with post-operative atrial fibrillation within the first 5 days postoperatively or up to hospital discharge, whichever occurs first
Hierarchical composite of all-cause death, ischemic stroke, systemic arterial embolism, unplanned hospital visit/readmission for cardiac reasons, and atrial fibrillation.Over the duration of the follow-up period to a common end date (mean follow-up of 5 years).Number of patients with a composite of all-cause death, ischemic stroke, systemic arterial embolism, unplanned hospital visit/readmission for cardiac reasons, and atrial fibrillation events, evaluated using the win ratio (thereby accounting for the difference in importance of these outcomes).

Secondary

MeasureTime frameDescription
Pericardial effusion without tamponadeFrom index surgery completion to within 30 days of index surgeryNumber of pericardial effusions that occur, excluding cardiac tamponade
Length of post-operative in-hospital stayOver the duration of the follow-up period to a common end date (mean follow-up of 5 years).Length of time the patient in hospital after their index cardiac surgery
DeathFrom index surgery completion to within 30 days of index surgeryOccurrence of death
Ischemic stroke or systemic arterial embolismFrom index surgery completion to within 30 days of index surgeryNumber of ischemic strokes or systemic arterial embolisms
Hospital readmission or unplanned hospital visitFrom index surgery completion to within 30 days of index surgeryNumber of hospital readmissions or unplanned hospital visits
Quality of life assessed by the European quality of life index version 5D (EQ-5D-5L) questionnaireOver the duration of the follow-up (mean follow-up of 5 years)The EQ-5D-5L consists of a descriptive system and the EQ visual analogue scale (EQ VAS) scale of 0-100 where the endpoints are labelled 'The best health you can image' and 'The worst health you can imagine'. The VAS can be used as a quantitative measure of health outcome that reflects the patient's own judgement. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension is measured on a 5 point scale: no problems, slight problems, moderate problems, severe problems and extreme problems.
Post-operative atrial fibrillation (POAF)Over the duration of the follow-up period to a common end date (mean follow-up of 5 years).Number of patients with post-operative atrial fibrillation

Other

MeasureTime frameDescription
Number of patients requiring re-operation for bleedingWithin 48 hours of index surgery completionSafety outcome
Number of patients with cardiac tamponadeWithin 30 days of index surgerySafety outcome
Number of patients with esophageal injuriesWithin 30 days of index surgerySafety outcome
Number of patients with left pleural interventionsWithin 30 days of index surgerySafety outcome
Number of patients with phrenic nerve injuriesWithin 30 days of index surgerySafety outcome

Countries

Austria, Canada, Italy, United States

Contacts

Primary ContactRichard Whitlock
Richard.Whitlock@phri.ca9055274322
Backup ContactPRINCE Coordinators
PRINCE@phri.ca

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026